Ocuphire Pharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Equipment, Net

Equipment, Net

3 Months Ended

Mar. 31, 2014

4 Equipment, Net



	March 31,		December 31,
	2014		2013

Furniture and fixtures	$	62,071	$	59,133
Office equipment		42,585		41,752
Lab and computer equipment		425,195		425,195
Leasehold improvements		119,841		119,841

Total equipment		649,692		645,921
Less: Accumulated depreciation		(589,793)		(580,749)

Net carrying amount	$	59,899	$	65,172

Depreciation expense was $9,044 and $9,316 for the three months ended March 31, 2014 and 2013, respectively.

- Definition

The entire disclosure for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, accounting policies and methodology, roll forwards, depreciation, depletion and amortization expense, including composite depreciation, accumulated depreciation, depletion and amortization expense, useful lives and method used, income statement disclosures, assets held for sale and public utility disclosures.

+ References + Details